Gold prices buoyed by tariff fears; US duties on 1-kilo bars spur supply concerns
Investing.com - Citizens JMP analyst Trevor Walsh reiterated a Market Outperform rating and $825.00 price target on Axon Enterprise (NASDAQ:AXON), a company with a market capitalization of $58 billion, following the company’s strong second-quarter 2025 results.
Axon reported non-GAAP earnings per share of $2.12, significantly exceeding the consensus estimate of $1.44. Revenue reached $668.5 million, representing a 33% year-over-year increase and surpassing the consensus forecast of $641.0 million.
The company’s adjusted EBITDA grew 38% year-over-year to $171.6 million, outperforming the consensus estimate of $160.2 million. Axon’s stock traded up approximately 3.9% in the aftermarket following the earnings announcement.
Axon President Josh Isner highlighted the company’s success with new offerings, stating, "We closed almost $150 million of bookings for our AI Era Plan in Q2 alone and over 30% of bookings this quarter came from new product categories."
The stock has gained approximately 30% year-to-date, outperforming the Russell 3000 index, which has risen about 7.3% during the same period.
In other recent news, Axon Enterprise Inc. reported impressive financial results for the second quarter of 2025, surpassing both earnings and revenue expectations. The company’s earnings per share were $2.12, significantly higher than the projected $1.46, representing a 45.21% surprise. Additionally, Axon achieved revenue of $669 million, exceeding the anticipated $640.3 million. These results highlight a strong performance and growth trajectory for the company. The financial community has taken note of these developments, with the earnings and revenue figures drawing particular attention. Analysts and investors alike are closely monitoring Axon’s continued progress. The positive earnings surprise underscores the company’s operational strength in the current market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.